| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEKTAR THERAPEUTICS | Chief R&D Officer | Common Stock | 25,221 | $1,368,995 | $54.28 | 22 Dec 2025 | Direct |
| NEKTAR THERAPEUTICS | Chief R&D Officer | Stock Option | 25,000 | 22 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NKTR | NEKTAR THERAPEUTICS | 22 Dec 2025 | 2 | $0 | 4 | Chief R&D Officer | 23 Dec 2025, 18:01 |
| NKTR | NEKTAR THERAPEUTICS | 21 Nov 2025 | 3 | -$62,802 | 4 | Chief R&D Officer | 25 Nov 2025, 20:30 |
| NKTR | NEKTAR THERAPEUTICS | 04 Sep 2025 | 4 | -$57,693 | 4 | Chief R&D Officer | 08 Sep 2025, 20:32 |
| NKTR | NEKTAR THERAPEUTICS | 02 Sep 2025 | 1 | -$14,598 | 4 | Chief R&D Officer | 04 Sep 2025, 21:02 |
| NKTR | NEKTAR THERAPEUTICS | 19 Aug 2025 | 2 | -$19,278 | 4 | Chief R&D Officer | 21 Aug 2025, 21:05 |
| NKTR | NEKTAR THERAPEUTICS | 19 May 2025 | 1 | -$7,177 | 4 | Chief R&D Officer | 21 May 2025, 20:08 |
| NKTR | NEKTAR THERAPEUTICS | 19 Feb 2025 | 1 | -$10,403 | 4 | Chief R&D Officer | 21 Feb 2025, 18:07 |
| NKTR | NEKTAR THERAPEUTICS | 19 Dec 2024 | 1 | -$48,048 | 4 | Chief R&D Officer | 20 Dec 2024, 20:33 |
| NKTR | NEKTAR THERAPEUTICS | 13 Dec 2024 | 3 | $0 | 4 | Chief R&D Officer | 17 Dec 2024, 20:55 |
| NKTR | NEKTAR THERAPEUTICS | 19 Nov 2024 | 1 | -$7,863 | 4 | Chief R&D Officer | 20 Nov 2024, 20:37 |
| NKTR | NEKTAR THERAPEUTICS | 19 Aug 2024 | 1 | -$8,788 | 4 | Chief R&D Officer | 20 Aug 2024, 21:15 |
| NKTR | NEKTAR THERAPEUTICS | 17 May 2024 | 1 | -$12,871 | 4 | Chief R&D Officer | 20 May 2024, 21:13 |
| NKTR | NEKTAR THERAPEUTICS | 20 Feb 2024 | 1 | -$6,130 | 4 | Chief R&D Officer | 22 Feb 2024, 20:19 |
| NKTR | NEKTAR THERAPEUTICS | 13 Dec 2023 | 1 | $0 | 4 | Chief R&D Officer | 15 Dec 2023, 18:07 |
| NKTR | NEKTAR THERAPEUTICS | 17 Nov 2023 | 1 | -$4,727 | 4 | Chief R&D Officer | 20 Nov 2023, 21:02 |
| NKTR | NEKTAR THERAPEUTICS | 16 Aug 2023 | 1 | -$7,568 | 4 | Chief R&D Officer | 17 Aug 2023, 20:08 |
| NKTR | NEKTAR THERAPEUTICS | 16 May 2023 | 1 | -$7,050 | 4 | Chief R&D Officer | 17 May 2023, 20:29 |
| NKTR | NEKTAR THERAPEUTICS | 16 Feb 2023 | 1 | -$31,452 | 4 | Chief R&D Officer | 17 Feb 2023, 20:00 |
| NKTR | NEKTAR THERAPEUTICS | 16 Nov 2022 | 1 | -$48,052 | 4 | Chief R&D Officer | 18 Nov 2022, 17:05 |
| NKTR | NEKTAR THERAPEUTICS | 18 Aug 2022 | 1 | -$342,779 | 4 | Chief R&D Officer | 19 Aug 2022, 18:27 |
| NKTR | NEKTAR THERAPEUTICS | 15 Aug 2022 | 3 | -$50,266 | 4 | Chief R&D Officer | 17 Aug 2022, 19:41 |
| NKTR | NEKTAR THERAPEUTICS | 15 May 2022 | 2 | -$85,608 | 4 | Chief R&D Officer | 17 May 2022, 21:40 |
| NKTR | NEKTAR THERAPEUTICS | 16 Feb 2022 | 1 | -$119,486 | 4 | Chief R&D Officer | 18 Feb 2022, 17:20 |
| NKTR | NEKTAR THERAPEUTICS | 16 Dec 2021 | 2 | $0 | 4 | Chief R&D Officer | 20 Dec 2021, 19:28 |
| NKTR | NEKTAR THERAPEUTICS | 15 Nov 2021 | 2 | -$274,636 | 4 | Chief R&D Officer | 17 Nov 2021, 17:11 |
| NKTR | NEKTAR THERAPEUTICS | 12 Oct 2021 | 1 | $0 | 4 | Chief R&D Officer | 14 Oct 2021, 21:10 |
| NKTR | NEKTAR THERAPEUTICS | 16 Aug 2021 | 1 | -$105,965 | 4 | Chief R&D Officer | 18 Aug 2021, 19:04 |
| NKTR | NEKTAR THERAPEUTICS | 17 May 2021 | 1 | -$569,331 | 4 | Chief R&D Officer | 19 May 2021, 19:08 |